Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


Human Beta-catenin GFP Citations (5)

Originally described in: Cortactin scaffolds Arp2/3 and WAVE2 at the epithelial zonula adherens.
Han SP, Gambin Y, Gomez GA, Verma S, Giles N, Michael M, Wu SK, Guo Z, Johnston W, Sierecki E, Parton RG, Alexandrov K, Yap AS J Biol Chem. 2014 Mar 14;289(11):7764-75. doi: 10.1074/jbc.M113.544478. Epub 2014 Jan 27.
PubMed Journal

Articles Citing Human Beta-catenin GFP

beta-TrCP1 Is a Vacillatory Regulator of Wnt Signaling. Long MJ, Lin HY, Parvez S, Zhao Y, Poganik JR, Huang P, Aye Y. Cell Chem Biol. 2017 Aug 17;24(8):944-957.e7. doi: 10.1016/j.chembiol.2017.06.009. Epub 2017 Jul 20. PubMed
LGK974, a PORCUPINE inhibitor, mitigates cytotoxicity in an in vitro model of Parkinson's disease by interfering with the WNT/beta-CATENIN pathway. Yang JM, Huang HM, Cheng JJ, Huang CL, Lee YC, Chiou CT, Huang HT, Huang NK, Yang YC. Toxicology. 2018 Dec 1;410:65-72. doi: 10.1016/j.tox.2018.09.003. Epub 2018 Sep 8. PubMed
ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway. Yu X, Wang M, Wu J, Han Q, Zhang X. J Exp Clin Cancer Res. 2019 Jan 28;38(1):40. doi: 10.1186/s13046-019-1031-4. PubMed
Tau acetylates and stabilizes beta-catenin thereby promoting cell survival. Liu E, Zhou Q, Xie AJ, Li X, Li M, Ye J, Li S, Ke D, Wang Q, Xu ZP, Li L, Yang Y, Liu GP, Wang XC, Li HL, Wang JZ. EMBO Rep. 2020 Mar 4;21(3):e48328. doi: 10.15252/embr.201948328. Epub 2020 Jan 13. PubMed
The role of CTNNB1 mutations and matrix metalloproteinases (MMPs) in anti-angiogenesis treatment of endometrial carcinoma. Berger AA, Kawaler EA, Dao F, Misirlioglu S, Fernandez EA, Olvera N, Van Oudenhove E, DeLair D, Levine DA. Gynecol Oncol. 2022 Sep 20:S0090-8258(22)01827-3. doi: 10.1016/j.ygyno.2022.09.013. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.